comparemela.com

Latest Breaking News On - Aileron therapeutics company profile - Page 1 : comparemela.com

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Sells 6,291 Shares

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) major shareholder Of Texas/Texas Am I. University sold 6,291 shares of the firm’s stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $3.30, for a total value of $20,760.30. Following the transaction, the insider now owns 1,783,851 shares in […]

Texas
United-states
Brookline
Exchange-commission
Sigma-planning-corp
Securities-exchange-commission
Texas-ami-university
Aileron-therapeutics-inc
Nasdaq
Aileron-therapeutics-company-profile
Aileron-therapeutics

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update
defenseworld.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from defenseworld.net Daily Mail and Mail on Sunday newspapers.

United-states
Texas
Aileron-therapeutics-inc
Nasdaq
Securities-exchange-commission
Aileron-therapeutics-company-profile
Sigma-planning-corp
Texas-ami-university
Aileron-therapeutics
Get-free-report
Exchange-commission

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 40,300 shares, a decline of 16.2% from the January 15th total of 48,100 shares. Currently, 1.0% of the shares of the stock are short sold. Based […]

Texas
United-states
Nasdaq
Aileron-therapeutics-company-profile
Aileron-therapeutics-inc
Sigma-planning-corp
Texas-capital-bank-wealth-management-services-inc
Renaissance-technologies
Envestnet-asset-management-inc
Geode-capital-management
Aileron-therapeutics

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 10.5% in September

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 8,500 shares, a decline of 10.5% from the September 15th total of 9,500 shares. Based on an average daily volume of 15,700 shares, the days-to-cover ratio […]

United-states
Aileron-therapeutics-company-profile
Envestnet-asset-management-inc
Geode-capital-management
Nasdaq
Aileron-therapeutics-inc
Renaissance-technologies
Aileron-therapeutics
Get-free-report
Capital-management
Envestnet-asset-management

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 50.8% in May

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,100 shares, a decline of 50.8% from the April 30th total of 36,800 shares. Approximately 0.6% of the company’s stock are sold short. Based on an average […]

Aileron-therapeutics-company-profile
Geode-capital-management
Nasdaq
Aileron-therapeutics-inc
Envestnet-asset-management-inc
Renaissance-technologies
Aileron-therapeutics
Get-rating
Asset-management
Capital-management
Aileron-therapeutics-daily

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.